drugset
drugset / Trial / NCT03898934

Vitamin D Supplementation in PCOS Patients

NCT03898934 ↗

Phase 4 Completed 170 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess whether Vitamin D supplementations for patients with polycystic ovary syndrome in conjunction with clomiphene citrate are beneficial or not

Timeline

Start
2019-04-01
Primary completion
2022-03-30
Completion
2022-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 2000 iu —

Indications

polycystic ovary syndrome